Ausdal Financial Partners’s Agilon Health AGL Stock Holding History

Ausdal Financial Partners’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-486	Closed	-$12.5K	–	942
2025 Q3	$12.5K	Buy	+486	New	+$18.4K	﹤0.01%	932

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NPCM

North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Ausdal Financial Partners's AGL Position: Q4 2025 in Review

Ausdal Financial Partners sold out of Agilon Health (AGL) in Q4 2025, closing a stake of 486 shares — an estimated $12.5K sold.

Ausdal Financial Partners first reported a position in AGL in Q3 2025 and held it in 1 quarter. The position peaked at $12.5K in Q3 2025. 194 funds tracked by Wall St. Rank hold AGL as of Q4 2025.

Ausdal Financial Partners reported no remaining Agilon Health position as of Q4 2025 after selling out during the quarter.
Ausdal Financial Partners sold 486 Agilon Health shares in Q4 2025, an estimated $12.5K.
Ausdal Financial Partners first reported a position in Agilon Health in Q3 2025 and held it in 1 quarter.
Ausdal Financial Partners's Agilon Health position peaked at $12.5K in Q3 2025.
194 funds tracked by Wall St. Rank held Agilon Health as of Q4 2025.

Based on Ausdal Financial Partners's 13F filing for Q4 2025, filed 13 Feb 2026.